Paclitaxel plus vinorelbine: an active regimen in metastatic breast cancer patients with prior anthracycline exposure. (Q40625819)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10690393%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Paclitaxel plus vinorelbine: an active regimen in metastatic breast cancer patients with prior anthracycline exposure (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10690393%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

main subject

metastatic breast cancer

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10690393%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10690393%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

M Martín

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10690393%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

A Casado

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10690393%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

I Garciía Carbonero

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10690393%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

L de Paz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10690393%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

C Esteban

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10690393%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

A Insa

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10690393%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

R Alfonso

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10690393%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

J García-Conde

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10690393%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 January 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10690393%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10690393%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10690393%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10690393%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

85-89

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10690393%20AND%20SRC:MED&resulttype=core&format=json

Treatment of breast cancer

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008374425246

7 January 2021

Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008374425246

7 January 2021

Paclitaxel. An update of its use in the treatment of metastatic breast cancer and ovarian and other gynaecological cancers

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008374425246

7 January 2021

Randomized comparison of vinorelbine and melphalan in anthracycline-refractory advanced breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008374425246

7 January 2021

Multicenter, randomized comparative study of two doses of paclitaxel in patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008374425246

7 January 2021

Phase II trial of paclitaxel by 3-hour infusion as initial and salvage chemotherapy for metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008374425246

7 January 2021

Vinorelbine tartrate and paclitaxel combinations: enhanced activity against in vivo P388 murine leukemia cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008374425246

7 January 2021

In vitro synergy of paclitaxel (Taxol) and vinorelbine (navelbine) against human melanoma cell lines

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008374425246

7 January 2021

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008374425246

7 January 2021

Paclitaxel administered by 1-hour infusion. Preliminary results of a phase I/II trial comparing two schedules

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008374425246

7 January 2021

Dose-intensive vinorelbine with concurrent granulocyte colony-stimulating factor support in paclitaxel-refractory metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008374425246

7 January 2021

Paclitaxel and vinorelbine in anthracycline-pretreated breast cancer: a phase II study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008374425246

7 January 2021

Vinorelbine and paclitaxel as first-line chemotherapy in metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008374425246

7 January 2021

Infusional paclitaxel and weekly vinorelbine chemotherapy with concurrent filgrastim for metastatic breast cancer: high complete response rate in a phase I-II study of doxorubicin-treated patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008374425246

7 January 2021

Phase I/II study of paclitaxel and vinorelbine in metastatic breast cancer.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008374425246

7 January 2021